BioSpace News Archive

Merus N.V. today announced the publication of an abstract for a poster presentation of early clinical data on the bispecific antibody petosemtamab in advanced gastric/esophageal adenocarcinoma (GEA) at the American Association for Cancer Research (AACR) Annual Meeting 2023 taking place in Orlando, Florida April 14-19, 2023.

Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”) today announced its participation in the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting, taking place in Orlando, Florida from April 14 through April 19, 2023, where VAL-083 data will be presented.

23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced results from the Phase 1 portion of its Phase 1/2a study evaluating 23ME-00610, an investigational antibody targeting CD200R1.

Teva Pharmaceutical Industries Ltd. announced that it will issue a press release on its first quarter 2023 financial results on Wednesday, May 10, 2023 at 7:00 a.m. ET.

MEI Pharma, Inc., a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, announced that its board of directors approved a 1-for-20 reverse stock split.

LivaNova PLC, a market-leading medical technology and innovation company, announced that Damien McDonald has resigned as Chief Executive Officer.

Biomerica, Inc., a global provider of advanced medical diagnostic and therapeutic products, announced its fiscal third quarter and nine month results ended February 28, 2023.

Geneius Biotechnology, Inc. announced the company will present a poster presentation at the upcoming American Association for Cancer Research Annual Meeting, taking place April 14-19, 2023, in Orlando, Florida.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

OncoOne, a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced two poster presentations highlighting new preclinical data from its oxMIF-targeting drug candidate pipeline at the upcoming American Association for Cancer Research Annual Meeting 2023, held from April 14-19, in Orlando, Florida.